Michael Klein

Partner
Full contact info

Experience

Thirty Madison Acquires Assets From The Pill Club in Section 363 Sale

June 20, 2023

Cooley advised Thirty Madison, a family of specialized healthcare brands, in its acquisition of certain assets from The Pill Club, following a sale process conducted by The Pill Club under Section 363 of the US Bankruptcy Code.

Read more

Related contacts

Bill Roegge
Partner, New York
Michael Klein
Partner, New York
Adam Dinow
Partner, New York
Eileen Marshall
Partner, Washington DC
Howard Morse
Partner, Washington DC
Gerard O'Shea
Partner, New York
Jason Savich
Partner, San Francisco
Judd Lauter
Special Counsel, San Francisco
Nathan Baum
Associate, New York
Daniel Han
Associate, New York
Lauren A. Reichardt
Associate, New York
DeVon Barnett
Associate, Washington DC
Scott D. Rudin
Associate, New York
Mor Agam
Associate, New York
Sai Yarramalla
Associate, Palo Alto
Jane Jeong
Associate, New York
Lois NaYeon Yoo
Associate, New York
Addison Pierce
Associate, Chicago
Rachel F. Katz
Associate, New York
David Dalton
Associate, Los Angeles Santa Monica
Caitlin Courtney
Associate, Palo Alto
Calvin Lee
Associate, New York
Denise Cahir
Senior Paralegal, New York

Related Practices & Industries

SoundHound AI Announces $125 Million New Loan Facility From Atlas Credit Partners

April 19, 2023

Cooley advised SoundHound AI, a leader in voice artificial intelligence, in the closing of a new $125 million loan facility from Atlas Credit Partners.

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Ellie Guadiana
Partner, Los Angeles Santa Monica
Milson Yu
Partner, Palo Alto
Savannah Harms
Associate, New York
William Beom Hong
Associate, Palo Alto
Stephanie Gentile
Partner, New York
Aaron Pomeroy
Partner, Colorado
Jonathan Rivinus
Partner, Colorado
Michael Klein
Partner, New York
Patrick Flanagan
Partner, New York
Nyron J. Persaud
Partner, New York
Sarah Lightdale
Partner, New York
Francis Wheeler
Partner, Colorado
Peter Burns
Of Counsel, Palo Alto
Matthew D. Silverman
Special Counsel, San Diego
Paul Moura
Special Counsel, New York
Amanda Pacheco
Associate, Palo Alto
Michelle Zhou
Associate, Palo Alto
Greg Reith
Associate, Washington DC
Rick Jantz
Associate, Los Angeles Santa Monica

Related Practices & Industries

Scorpion Therapeutics Announces Collaboration and License Agreement With Pierre Fabre to Co-Develop and Commercialize STX-721 and STX-241

April 4, 2023

Boston – April 4, 2023 Cooley advised Scorpion Therapeutics on its exclusive license agreement with Pierre Fabre to co-develop and commercialize STX-721 and STX-241. Lawyers Christophe Beauduin, Carly Robinson, Michael Klein, Evan Lazerowitz and Aaron Pomeroy led the Cooley team.

The exclusive collaboration and license agreement granted Pierre Fabre a royalty-bearing license to develop and commercialize STX-721 and STX-241, two next-generation mutant epidermal growth factor receptor (EGFR) inhibitors for patients with EGFR-mutant non-small cell lung cancer. Scorpion will lead clinical development of STX-721, and Pierre Fabre will lead clinical development of STX-241. Scorpion will retain commercialization rights to STX-721 and STX-241 in the US, Canada and Japan, while Pierre Fabre will be responsible for commercialization activities in all other territories – with a focus on Europe and China.

Under the terms of the agreement, Scorpion will receive a combined $65 million from an upfront payment and achievement of near-term milestones – and will be eligible to receive up to a total of $553 million in potential milestone payments. In addition, Pierre Fabre will pay Scorpion tiered percentage royalties on a licensed product-by-licensed product basis, ranging from mid-single to mid-teens based on annual net sales of each licensed product in territories excluding the US, Canada and Japan. Scorpion will pay Pierre Fabre tiered percentage royalties based on a licensed product-by-licensed product basis, ranging from low-single to low-double digits on annual net sales of each licensed product in the US. The companies will share global development expenses based on a pre-specified cost-sharing arrangement.

Read more

Related contacts

Christophe Beauduin
Special Counsel, New York
Carly Robinson
Associate, Reston
Michael Klein
Partner, New York
Evan Lazerowitz
Associate, New York
Aaron Pomeroy
Partner, Colorado

Sixth Street Invests in Blueprint Medicines

July 7, 2022

Cooley advised global investment firm Sixth Street on its strategic investment in Blueprint Medicines, a global precision therapy company that invents life-changing therapies for people with cancer and blood disorders. Lawyers Mischi a Marca, Matt Browne, Matt Scarano, Addison Pierce, Matt Kong and Nick Neuteufel led the Cooley team advising Sixth Street. 

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Matt Browne
Partner, San Diego
Matthew S. Scarano
Associate, San Diego
Addison Pierce
Associate, Chicago
Matt Kong
Associate, San Francisco
Michael Tuscan
Partner, Washington DC
Jon Cousin
Associate, Washington DC
Tanya Heare-Rowlands
Special Counsel, London
Matthew Everhart
Patent Agent, Washington DC
Jeffery Wyzykowski
Patent Agent, Washington DC
Matthew Scheideman
Patent Agent, Washington DC
Charity Williams
Partner, San Diego
Freddy Yip
Associate, Hong Kong
Zack Gong
Associate, Shanghai
Natasha Leskovsek
Of Counsel, Washington DC
Phil Mitchell
Partner, New York
Jennifer Shanley
Special Counsel, New York
Elizabeth Anne Wright
Partner, Brussels
Aaron Pomeroy
Partner, Colorado
Michael Klein
Partner, New York
Paul Springer
Associate, New York
Megan Browdie
Partner, Washington DC
Howard Morse
Partner, Washington DC

Related Practices & Industries

Cooley Secures Win in Mallinckrodt Chapter 11 Case

February 9, 2022

Cooley has been representing the Official Committee of Unsecured Creditors of Mallinckrodt during Mallinckrodt’s ongoing bankruptcy proceedings, in which the pharmaceutical company’s Chapter 11 plan of reorganization was recently confirmed after a contentious multiweek trial, marking a defining moment in the case. Cooley partners Cullen Speckhart, Ian Shapiro, Philip Bowman, Michael Klein, Cathy Hershcopf and Jonathan Kim led the team advising the Official Committee of Unsecured Creditors.

Read more

Related contacts

Cullen Drescher Speckhart
Partner in Charge – Washington, DC, Washington DC
Ian Shapiro
Partner in Charge – New York, New York
Philip Bowman
Partner, New York
Michael Klein
Partner, New York
Cathy Hershcopf
Partner, New York
Russell Capone
Partner, New York
Bobby Earles
Partner, Chicago
Aric Wu
Partner, New York
Sonia Nath
Partner, Washington DC
Reed Smith
Special Counsel, New York
Joshua Siegel
Special Counsel, Washington DC
Erica Richards
Special Counsel, New York
Summer M. McKee
Associate, New York
Lauren A. Reichardt
Associate, New York
Evan Lazerowitz
Associate, New York
Georgina Inglis
Associate, Washington DC
Charlie Low
Associate, New York
Paul Springer
Associate, New York
Courtney Gladstone
Associate, Washington DC
Jeremiah P. Ledwidge
Associate, New York

Related Practices & Industries

View more

Rankings & accolades

  • New York Super Lawyers: New York Rising Star

  • Legal Aid Society Immigration Law Unit: Outstanding Pro Bono Service

Memberships & affiliations

Turnaround Management Association